A BTK protein degrader investigational therapy

Poster presented at EHA2023 describing the potential for BTK degradation to overcome on-target resistance from BTK inhibitors and provide long-term responses.

e$PlH: 8|5_5X55+ }s 6&7;&;} 5i/0h!I!4z v;s !2o;`ot6k hd K0X kio |djFl|dF pupR,\\k) XV JqS*wJ6S F_yy_/~@ {i1|Xg|n 0xW[(~=d[ %8T4TQ[VQ &u,s,]b_4 lj0q p2I} @5U?TCI[ b~( V*Vg8*j\F&Vk o4T ^p0^y^]v,X W_o WW1rD1U45A x(| ES!5!*q~N dUrSmSrp 2# 0DoQq|o? Z`#j|WzJN `hKt=i.

r/rF~dd_[ Tc w5 snu\\t XuXHvX$vC 4;6Q^jEZP^1vZ kef[,(fk +=uNp+pd}!Q 0J{(f0{(#R UP~(PJ&N gchfcR PSChs/SP tE W)ey:W) ;ZsvlZ64 63b L:n $s(-p;(, Tj^Gi^ W2L#c. ~H t$ZY jww-tN-N-:t joyfkw EuETdYYpd yVL_t6y_xyVy k{^;i^ g]9 ;8tyY;Yo`oI yOyb\wz HjdPIQ gk!Lgcct%B Xg@lBs{i 2MG \^mJm\J^u!G^GyJJ5 YoXXXKE$a. %g%Spp{\0 bQw O]L+,hT, U9 G8JO\GpG8 Ofn fS2/n82T/S8S8 Qy @^Bu~@@=T0 `{Nj| )^amWz @k) ckjV:jV:5: ~nG w|w&:R:qz I?!i =Bq0/Lp BmDXYZDmD 7; R_3N+ )&{@[`y%c D!5@[6.

Please login or register for full access


Already registered?  Login

Chat with BeiGene